Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Nutrients ; 13(11)2021 Nov 10.
Artículo en Inglés | MEDLINE | ID: mdl-34836270

RESUMEN

The mainstay of phenylketonuria treatment is a low protein diet, supplemented with phenylalanine (Phe)-free protein substitutes and micronutrients. Adhering to this diet is challenging, and even patients with good metabolic control who follow the dietary prescriptions in everyday life ignore the recommendations occasionally. The present study explores the ability of slow-release large neutral amino acids (srLNAAs) to prevent Phe increase following a Phe dietary load. Fourteen phenylketonuric patients aged ≥13 years were enrolled in a 6-week protocol. Oral acute Phe loads of 250 and 500 mg were added to the evening meal together with srLNAAs (0.5 gr/kg). Phe and tyrosine were dosed before dinner, 2h-after dinner, and after the overnight fast. After oral Phe loads, mean plasma Phe remained stable and below 600 µmol/L. No Phe peaks were registered. Tyrosine levels significantly increased, and Phe/Tyrosine ratio decreased. No adverse events were registered. In conclusion, a single oral administration of srLNAAs at the dose of 0.5 gr/kg is effective in maintaining stable plasma Phe during acute oral loads with Phe-containing food and may be added to the dietetic scheme in situations in which patients with generally good adherence to diet foresee a higher than prescribed Phe intake due to their commitments.


Asunto(s)
Aminoácidos Neutros/administración & dosificación , Suplementos Dietéticos , Fenilalanina/administración & dosificación , Fenilcetonurias/tratamiento farmacológico , Adolescente , Adulto , Aminoácidos/administración & dosificación , Aminoácidos Neutros/sangre , Aminoácidos Neutros/uso terapéutico , Dieta , Femenino , Humanos , Italia , Masculino , Micronutrientes/uso terapéutico , Fenilalanina/sangre , Fenilalanina/uso terapéutico , Fenilcetonurias/sangre , Tirosina/sangre , Tirosina/uso terapéutico , Adulto Joven
2.
J Nutr Biochem ; 53: 20-27, 2018 03.
Artículo en Inglés | MEDLINE | ID: mdl-29175141

RESUMEN

Phenylketonuria treatment mainly consists of a phenylalanine-restricted diet but still results in suboptimal neuropsychological outcome, which is at least partly based on cerebral monoamine deficiencies, while, after childhood, treatment compliance decreases. Supplementation of large neutral amino acids (LNAAs) was previously demonstrated in young phenylketonuria mice to target all three biochemical disturbances underlying brain dysfunction in phenylketonuria. However, both its potential in adult phenylketonuria and the comparison with the phenylalanine-restricted diet remain to be established. To this purpose, several LNAA supplements were compared with a severe phenylalanine-restricted diet with respect to brain monoamine and amino acid concentrations in adult C57Bl/6 Pah-enu2 mice. Adult phenylketonuria mice received a phenylalanine-restricted diet, unrestricted diet supplemented with several combinations of LNAAs or AIN-93M control diet for 6 weeks. In addition, adult wild-type mice on AIN-93M diet served as controls. The severe phenylalanine-restricted diet in adult phenylketonuria mice significantly reduced plasma and brain phenylalanine and restored brain monoamine concentrations, while brain concentrations of most nonphenylalanine LNAAs remained subnormal. Supplementation of eight LNAAs was similarly effective as the severe phenylalanine-restricted diet to restore brain monoamines, while brain and plasma phenylalanine concentrations remained markedly elevated. These results provide biochemical support for the effectiveness of the severe phenylalanine-restricted diet and showed the possibilities of LNAA supplementation being equally effective to restore brain monoamines in adult phenylketonuria mice. Therefore, LNAA supplementation is a promising alternative treatment to phenylalanine restriction in adult phenylketonuria patients to further optimize neuropsychological functioning.


Asunto(s)
Aminoácidos Neutros/farmacología , Encéfalo/efectos de los fármacos , Encéfalo/metabolismo , Fenilcetonurias/dietoterapia , Aminoácidos Neutros/sangre , Aminoácidos Neutros/metabolismo , Animales , Monoaminas Biogénicas/metabolismo , Suplementos Dietéticos , Modelos Animales de Enfermedad , Ingestión de Alimentos/efectos de los fármacos , Femenino , Masculino , Ratones Endogámicos C57BL , Ratones Mutantes , Fenilalanina , Fenilcetonurias/metabolismo
3.
Biomed Res Int ; 2016: 2912418, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27366740

RESUMEN

Tryptophan (Trp) plays an essential role in pig behavior and growth performances. However, little is known about Trp's effects on tight junction barrier and intestinal health in weaned pigs. In the present study, twenty-four (24) weaned pigs were randomly assigned to one of the three treatments with 8 piglets/treatments. The piglets were fed different amounts of L-tryptophan (L-Trp) as follows: 0.0%, 0.15, and 0.75%, respectively, named zero Trp (ZTS), low Trp (LTS), and high Trp (HTS), respectively. No significant differences were observed in average daily gain (ADG), average daily feed intake (ADFI), and gain: feed (G/F) ratio between the groups. After 21 days of the feeding trial, results showed that dietary Trp significantly increased (P < 0.05) crypt depth and significantly decreased (P < 0.05) villus height to crypt depth ratio (VH/CD) in the jejunum of pig fed HTS. In addition, pig fed HTS had higher (P < 0.05) serum diamine oxidase (DAO) and D-lactate. Furthermore, pig fed HTS significantly decreased mRNA expression of tight junction proteins occludin and ZO-1 but not claudin-1 in the jejunum. The number of intraepithelial lymphocytes and goblet cells were not significantly different (P > 0.05) between the groups. Collectively, these data suggest that dietary Trp supplementation at a certain level (0.75%) may negatively affect the small intestinal structure in weaned pig.


Asunto(s)
Suplementos Dietéticos , Intestinos/anatomía & histología , Proteínas de Uniones Estrechas/metabolismo , Triptófano/farmacología , Destete , Amina Oxidasa (conteniendo Cobre)/sangre , Aminoácidos Neutros/sangre , Animales , Crecimiento y Desarrollo/efectos de los fármacos , Intestinos/efectos de los fármacos , Yeyuno/efectos de los fármacos , Yeyuno/metabolismo , ARN Mensajero/genética , ARN Mensajero/metabolismo , Sus scrofa
4.
Amino Acids ; 45(3): 419-30, 2013 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-22677921

RESUMEN

The ingestion of large neutral amino acids (LNAA), notably tryptophan, tyrosine and the branched-chain amino acids (BCAA), modifies tryptophan and tyrosine uptake into brain and their conversion to serotonin and catecholamines, respectively. The particular effect reflects the competitive nature of the transporter for LNAA at the blood-brain barrier. For example, raising blood tryptophan or tyrosine levels raises their uptake into brain, while raising blood BCAA levels lowers tryptophan and tyrosine uptake; serotonin and catecholamine synthesis in brain parallel the tryptophan and tyrosine changes. By changing blood LNAA levels, the ingestion of particular proteins causes surprisingly large variations in brain tryptophan uptake and serotonin synthesis, with minimal effects on tyrosine uptake and catecholamine synthesis. Such variations elicit predictable effects on mood, cognition and hormone secretion (prolactin, cortisol). The ingestion of mixtures of LNAA, particularly BCAA, lowers brain tryptophan uptake and serotonin synthesis. Though argued to improve physical performance by reducing serotonin function, such effects are generally considered modest at best. However, BCAA ingestion also lowers tyrosine uptake, and dopamine synthesis in brain. Increasing dopamine function in brain improves performance, suggesting that BCAA may fail to increase performance because dopamine is reduced. Conceivably, BCAA administered with tyrosine could prevent the decline in dopamine, while still eliciting a drop in serotonin. Such an LNAA mixture might thus prove an effective enhancer of physical performance. The thoughtful development and application of dietary proteins and LNAA mixtures may thus produce treatments with predictable and useful functional effects.


Asunto(s)
Aminoácidos Neutros/química , Aminoácidos Neutros/metabolismo , Química Encefálica , Encéfalo/metabolismo , Suplementos Dietéticos , Aminoácidos Neutros/sangre , Aminoácidos Neutros/farmacología , Animales , Barrera Hematoencefálica/efectos de los fármacos , Barrera Hematoencefálica/metabolismo , Encéfalo/efectos de los fármacos , Química Encefálica/efectos de los fármacos , Proteínas en la Dieta/química , Proteínas en la Dieta/metabolismo , Proteínas en la Dieta/farmacología , Humanos
5.
Appl Physiol Nutr Metab ; 36(5): 671-81, 2011 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-21980992

RESUMEN

This study investigated the effects of high-dose large neutral amino acid (LNAA) supplementation on attenuating fatigue-induced decrements in exercise and motor skill performance in Australian Rules Football (ARF) players. Fifteen subelite ARF players participated in 3 testing sessions separated by 7 days. Players completed an initial control trial involving a reactive motor skills test (RMST) and a reactive agility test (RAT) carried out before and after fatiguing exercise. In the subsequent experimental trials, players ingested a serotonin-depleting or protein control (PC) LNAA mixture 3 h before testing, allocated in a double-blind randomized cross-over design. Blood samples were taken at presupplementation and pre- and postexercise for analysis of plasma amino acid, insulin, and metabolite concentrations. The effect of the LNAA was established as the difference in the change in the mean RMST and RAT test scores among the depleting, PC, and baseline (BL) trials. Mean overall repetition time of the RAT was moderately improved by -5.2% ± 3.4% (mean ± 90% confidence limits; effect size -0.45 ± 0.28) after ingestion of the serotonin-depleting mixture compared with the BL trial. Serotonin-depleting and PC supplements had a divergent effect on mean repetition time after fatiguing exercise in RMST: depleting serotonin elicited a small improvement (-3.0% ± 2.7%) in motor skill performance in contrast to a small decrement (2.4% ± 2.7%) after ingestion of the PC mixture, when compared to the BL. High-dose serotonin-"depleting" LNAA supplementation given 3 h prior to intermittent high-intensity exercise improved reactive motor skill and agility performance in ARF players.


Asunto(s)
Aminoácidos Neutros/uso terapéutico , Rendimiento Atlético , Cognición , Toma de Decisiones , Suplementos Dietéticos , Fatiga/prevención & control , Destreza Motora , Adulto , Aminoácidos Neutros/administración & dosificación , Aminoácidos Neutros/sangre , Atletas/psicología , Rendimiento Atlético/psicología , Australia , Estudios Cruzados , Proteínas en la Dieta/administración & dosificación , Proteínas en la Dieta/uso terapéutico , Método Doble Ciego , Fatiga/sangre , Fatiga/fisiopatología , Fatiga/psicología , Fútbol Americano , Humanos , Masculino , Resistencia Física , Antagonistas de la Serotonina/administración & dosificación , Antagonistas de la Serotonina/sangre , Antagonistas de la Serotonina/uso terapéutico , Triptófano/antagonistas & inhibidores , Triptófano/sangre , Adulto Joven
6.
J Anim Sci ; 83(7): 1568-80, 2005 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-15956466

RESUMEN

Our objectives were to investigate and compare the effects of supplemental Mg, Trp, vitamin E (vit E), and vitamin C (vit C) on stress responses of pigs undergoing transport simulation. In this study, 126 pigs (25.1 +/- 4.4 kg BW) were allocated to one of the six following treatments: 1) negative control (no supplementation); 2) positive control (i.m. injection with 0.5 mg of carazolol/20 kg BW 12 h before vibration, beta-blocker); 3) Trp (additional amount of 6 g/kg of feed for 5 d, as-fed basis); 4) Mg (3 g/L drinking water for 2 d); 5) vit E (additional amount of 150 mg/kg of feed for 21 d, as-fed basis); 6) or vit C (additional amount of 300 mg/kg of feed for 21 d, as-fed basis). Pigs were treated in groups of three, and each treatment was replicated seven times. Feed and water intake were not different among treatments. Heart rate variables (mean, peak, and minimum heart rate, ventricular ectopic beats, and ST elevation of Channels A and B) and heart rate variability were registered from the night before vibration. Pigs were subjected to vibration in a transport simulator (8 Hz, 3 m/s) for 2 h and allowed to recover for 2 h. Generally, the positive control pigs had the lowest heart rate values (mean, peak, minimum heart rate, ST elevation of Channel A; P < 0.05), whereas Mg and Trp decreased ventricular ectopic beats and ST elevation of Channel B, respectively. The effect of vit C and E as vagal stimulators was clearly visible, whereas carazolol and Mg clearly blocked the sympathetic pathways of the autonomic nervous system. During vibration, the negative control pigs lay the least, and Mg pigs the most (P < 0.05). Salivary cortisol concentrations (taken before and after vibration and after recovery) showed that vit E pigs produced the least cortisol during stress periods. Intermediary metabolites (glucose, lactate, creatine kinase, and NEFA) were analyzed in plasma from blood taken before and after vibration. At the two sampling points, the vit E and Mg pigs had the lowest NEFA concentrations (P < 0.05), and the vit E pigs also had the lowest lactate concentrations before vibration. Urine samples were collected before and after vibration to determine catecholamine concentrations; only negative control pigs had an increase (P = 0.04) in epinephrine concentration, despite large individual variation. In general, these results indicate that the supplementation of Trp, Mg, vit E, or vit C improved coping ability of pigs during vibration comparison with the negative control treatment. A muscular injection of carazolol influenced only the heart rate variables.


Asunto(s)
Conducta Animal/efectos de los fármacos , Suplementos Dietéticos , Frecuencia Cardíaca/efectos de los fármacos , Estrés Fisiológico/veterinaria , Porcinos/fisiología , Adaptación Psicológica/efectos de los fármacos , Aminoácidos Neutros/sangre , Aminoácidos Neutros/efectos de los fármacos , Animales , Ácido Ascórbico/administración & dosificación , Ácido Ascórbico/sangre , Ácido Ascórbico/farmacología , Catecolaminas/orina , Femenino , Hidrocortisona/análisis , Análisis de los Mínimos Cuadrados , Magnesio/administración & dosificación , Magnesio/sangre , Magnesio/farmacología , Masculino , Propanolaminas/administración & dosificación , Propanolaminas/farmacología , Saliva/química , Estrés Fisiológico/etiología , Estrés Fisiológico/prevención & control , Triptófano/administración & dosificación , Triptófano/sangre , Triptófano/farmacología , Vibración/efectos adversos , Vitamina E/administración & dosificación , Vitamina E/sangre , Vitamina E/farmacología
7.
Physiol Behav ; 81(4): 585-93, 2004 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-15178151

RESUMEN

Brain serotonin influences food intake and mood. It is synthesised from tryptophan (Trp) of which uptake in the brain is dependent on plasma ratio of tryptophan to the sum of other large neutral amino acids (Trp-LNAA). A carbohydrate-rich diet increases this ratio, whereas a protein-rich diet decreases it. Yet, if the protein source is alpha-lactalbumin the ratio increases. It is, however, unknown whether this also happens in the context of a regular diet (15% protein). We studied the effect of an alpha-lactalbumin supplement combined with regular diet on plasma Trp-LNAA ratio, serum prolactin (marker of serotonin synthesis), food intake, appetite, macronutrient preference and mood. Eighteen healthy males participated in a double-blind, randomised, placebo-controlled, crossover study. One hour after breakfast they received a drink containing alpha-lactalbumin and carbohydrates (AS) or carbohydrates (PS) only. Plasma Trp-LNAA ratio, serum prolactin, food intake, appetite, macronutrient preference and mood were assessed before and 90 min after consumption of the supplement. Changes of plasma Trp-LNAA ratio differed (P<.001) between both supplements, increasing by 16% after AS and decreasing by 17% after PS. Decrease of serum prolactin was slightly smaller after AS than after PS (P=.083). Appetite, food intake, macronutrient preference or mood did not differ between supplements. We conclude that an alpha-lactalbumin-enriched supplement combined with a regular diet increases plasma Trp-LNAA ratio and may influence serum prolactin, but we could not demonstrate effects on appetite, food intake, macronutrient preference and mood.


Asunto(s)
Aminoácidos Neutros/sangre , Carbohidratos de la Dieta/metabolismo , Lactalbúmina/metabolismo , Prolactina/sangre , Triptófano/sangre , Adolescente , Adulto , Afecto/fisiología , Análisis de Varianza , Apetito/fisiología , Dieta , Proteínas en la Dieta/administración & dosificación , Proteínas en la Dieta/metabolismo , Suplementos Dietéticos , Método Doble Ciego , Ingestión de Alimentos/fisiología , Preferencias Alimentarias/fisiología , Humanos , Insulina/sangre , Lactalbúmina/administración & dosificación , Masculino , Valores de Referencia , Serotonina/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA